Peter van der Velden, MBA, M.Sc., Managing General Partner at Lumira Ventures, Toronto, Ontario. See sector focus and contact routes.
Peter van der Velden, Managing General Partner at Lumira Ventures, invests in North American biotechnology, medical device, and digital health companies primarily at the Series A and B stages with check sizes reaching $52 million for Series B financings. His firm, Canada’s largest dedicated life sciences VC, maintains a broad thesis across biotech and medtech while launching the Cancer Breakthrough Fund to target innovative cancer companies, often skewed to Canadian firms. Van der Velden also focuses on growth equity in companies transitioning from development to sales, including non-traditional medicines, spin-outs, restructurings, and public entities. Lumira’s portfolio includes an impressive array of transformative private and public life sciences companies across North America, though specific notable portfolio names are not listed in the provided sources.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Toronto when building a target list.
Investors like Peter van der Velden, MBA, M.Sc. · Full investor directory · Investor access · Company funding database